+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

From
Post-surgical Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Post-surgical Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
CNS Bacterial Infections - Pipeline Insight, 2025 - Product Thumbnail Image

CNS Bacterial Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hospital Acquired Candida Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Hospital Acquired Candida Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Multidrug Resistant Acinetobacter Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Multidrug Resistant Acinetobacter Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Rhinovirus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Rhinovirus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Staphylococcus Aureus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Staphylococcus Aureus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Scedosporium Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Scedosporium Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Eye Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Eye Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sternal Wound Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Sternal Wound Infection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Rotavirus Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Rotavirus Infections - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Herpes Simplex - Pipeline Insight, 2025 - Product Thumbnail Image

Herpes Simplex - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
Topical Skin Infection Treatment - Pipeline Insight, 2025 - Product Thumbnail Image

Topical Skin Infection Treatment - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Influenza A Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Influenza A Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
Schistosomiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Schistosomiasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025 - Product Thumbnail Image

Community-acquired Pneumonia (CAP) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
West Nile - Pipeline Insight, 2025 - Product Thumbnail Image

West Nile - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more